STOCK TITAN
  1. Home
  2. News
  3. BDPT

Bioadaptives Inc - BDPT STOCK NEWS

Welcome to our dedicated news page for Bioadaptives (Ticker: BDPT), a resource for investors and traders seeking the latest updates and insights on Bioadaptives.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bioadaptives's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bioadaptives's position in the market.

News
BioAdaptives Targets Multi-Billion Dollar Sleep Market with SleepEZ™ Natural Supplement
Rhea-AI Summary
BioAdaptives, Inc. is targeting the multi-billion dollar sleep aid industry with its popular natural sleep supplement, SleepEZ™. Chronic insomnia affects approximately 30% of the world's population. Sleep experts are meeting at the World Sleep Congress to discuss the latest developments in sleep medicine. SleepEZ™ works with the circadian rhythm to promote restful and sustained sleep without drowsiness. The global sleep aid market was valued at $59 billion in 2020 and is projected to reach $111 billion by 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
BioAdaptives, Inc. Celebrates Nine Years of Commercial Success in Equine Nutrition
Rhea-AI Summary
BioAdaptives celebrates success of Equine supplement products
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-37.5%
Tags
none
-
News
BioAdaptives Announces Nationwide Launch of Lung Fortress(TM) Natural Supplement
Rhea-AI Summary
BioAdaptives launches Lung Fortress, a potent supplement to support pulmonary health amid rising concerns for seasonal respiratory problems
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.35%
Tags
none
News
BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
Rhea-AI Summary
BioAdaptives develops PluriPain®-PMS, an advanced anti-inflammatory and mood-enhancing Women’s Health formula.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.75%
Tags
none
-
News
BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs
Rhea-AI Summary
BioAdaptives, Inc. announces new directions and activities to expand its role in providing additional products for human health, including specific sectors such as Women’s and Men’s Health. The company's subsidiary, LiveStock Impact, Inc., will focus on animal health and botanical drugs. New Directors with relevant expertise have been appointed. The company aims to build a more diverse and global enterprise through collaborations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.89%
Tags
none
-
News
LiveStock Impact, Inc., a Wholly Owned Subsidiary of BioAdaptives, Inc., Announces the Appointments of two Experts to Board of Directors
Rhea-AI Summary
LiveStock Impact, Inc. appoints Bruce Colclasure and Charles Timmerman to its Board of Directors, expecting to enhance the creation of superior animal health products and global market penetration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.33%
Tags
management
News
BioAdaptives, Inc. Announces the Spin-off Its LiveStock Impact Division as a Wholly Owned Subsidiary, LiveStock Impact, Inc., Focusing on New Product Development and Global Marketing of Animal Health Supplement Products and Botanical Drugs
Rhea-AI Summary
BioAdaptives, Inc. announces spin-off of LiveStock Impact Division as wholly owned subsidiary. LiveStock Impact, Inc. to expand globally for veterinary supplements. Anticipates rapid growth in global animal product sales.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
33.33%
Tags
none
-
News
BioAdaptives, Inc. Announces Intention to Spin off Its Livestock Impact Division as a Wholly-owned Subsidiary With Further Expansion in Botanical Drug Development and Animal Health Markets
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
News
BioAdaptives Signs Non-Exclusive License With LY Research to Market Patented Bioavailable Resveratrol for Both Animals and Humans
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
none
News
BioAdaptives Inc. (OTC BDPT) Announces New Appointment to the Board of Directors - Visionary Futurist , Wellness Pioneer and Marketer, David Allen, PhD
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
management
Stock BDPT logo
Bioadaptives Inc

OTC:BDPT

BDPT Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

BDPT Stock Data

486.08k
970.36M
3.08%
Packaged Foods
Consumer Defensive
Link
United States
Las Vegas

About BDPT

bioadaptives is a research, development, and educational company. bioadaptives, inc. pursues nutraceutical research and development. we are making strides toward supplying solutions demanded by an increasingly aware population worldwide. we are a development stage company building a base of intellectual property and products that are patent pending and in demand in today’s market place. bioadaptives™ provides solutions in the form of nutraceuticals designed to aid in cognition, focus, fatigue reduction, increased testosterone, improved overall emotional and physical wellness, healing, and anti-aging.